Stockscreener 앱 받기
0.4442
0.67%
-0.003
전일 마감가:
$0.4472
열려 있는:
$0.459
하루 거래량:
1.01M
Relative Volume:
2.98
시가총액:
$47.79M
수익:
$1.29M
순이익/손실:
$-29.87M
주가수익비율:
-1.2339
EPS:
-0.36
순현금흐름:
$-14.70M
1주 성능:
-4.29%
1개월 성능:
-28.80%
6개월 성능:
-9.35%
1년 성능:
-39.13%
1일 변동 폭
$0.44
$0.4781
1주일 범위
$0.43
$0.5157
52주 변동 폭
$0.3951
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
명칭
VolitionRX Ltd
전화
646 650 1351
주소
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
VNRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.4442 | 53.28M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
538.92 | 202.69B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
209.06 | 151.03B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
635.40 | 50.99B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.92 | 40.00B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.55 | 34.98B | 15.70B | 1.24B | 2.01B | 6.9036 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-08 | 개시 | H.C. Wainwright | Buy |
| 2023-02-01 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-02-17 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-16 | 개시 | Maxim Group | Buy |
| 2018-05-14 | 재확인 | The Benchmark Company | Buy |
| 2016-09-07 | 재확인 | Rodman & Renshaw | Buy |
| 2016-02-01 | 개시 | Rodman & Renshaw | Buy |
모두보기
VolitionRX Ltd 주식(VNRX)의 최신 뉴스
Nu.Q Vet Cancer Tests Donated: Volition Supports HOPE AACR Crisis Dogs at Conference - Stock Titan
Volitionrx (VNRX) president Reynolds buys $56,100 in shares By Investing.com - Investing.com South Africa
Still buys VolitionRx (VNRX) shares and warrants for $24,518 By Investing.com - Investing.com South Africa
Volitionrx director Innes buys $49k in shares - Investing.com
Volitionrx (VNRX) president Reynolds buys $56,100 in shares - Investing.com India
Still buys VolitionRx (VNRX) shares and warrants for $24,518 - Investing.com
VolitionRX Executives and Directors Increase Their Holdings - TradingView
[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan
VolitionRx insider adds 48,076 warrants, $0.60 exercise price - Stock Titan
Using fundamentals and technicals on VolitionRx LimitedWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
VolitionRx raises ~$5.4M; $0.60 5-year warrants attached - Stock Titan
Does VolitionRx Limited show high probability of rebound2025 Growth vs Value & Long-Term Growth Plans - newser.com
VNRX raises ~$5.4M net; $0.60 five-year warrants in unit deal - Stock Titan
Can VolitionRX Limited stock sustain free cash flowGDP Growth & Safe Capital Growth Plans - newser.com
Published on: 2025-10-13 09:58:07 - newser.com
Published on: 2025-10-13 06:57:47 - newser.com
VolitionRx announces offering of common stock and warrants, no amount given - MSN
VolitionRx prices $6 million public offering of common stock and warrants By Investing.com - Investing.com South Africa
VolitionRx prices $6 million public offering of common stock and warrants - Investing.com India
VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants - GuruFocus
VolitionRx Prices Public Offering Of 11.55 Mln Shares And Warrants At $0.52/set; Shares Fall - Nasdaq
$6.0M Gross Proceeds — VolitionRx Prices 11.55M Shares & Warrants; Close Expected Oct 14, 2025 - Stock Titan
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga
VolitionRx (VNRX) Plans Public Offering to Bolster Development a - GuruFocus
Volitionrx stock tumbles on proposed public offering By Investing.com - Investing.com Nigeria
VolitionRx announces proposed public offering of common stock By Investing.com - Investing.com Australia
Volitionrx stock tumbles on proposed public offering - Investing.com
15% Overallotment Option: VolitionRx Proposes Underwritten Offering of Common Stock & Warrants - Stock Titan
Live market analysis of VolitionRx LimitedJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
VNRX Form 4: RSU tax withholding cancels 6,110 shares - Stock Titan
VNRX Form 4: 105,184-share disposition; 326,451 shares remain - Stock Titan
VolitionRx insider report: 4,620 shares withheld for RSU taxes - Stock Titan
VNRX Insider: 17,333 RSUs Settled; 8,146 Shares Retained for Tax - Stock Titan
VNRX insider settles 13,000 RSUs; 5,850 shares retained for taxes - Stock Titan
VolitionRx Limited Stock Analysis and ForecastPrice Momentum Alerts & Build Diversified Portfolios With Ease - earlytimes.in
VolitionRx Insider: 15,333 RSUs Settled; 5,389 Shares Withheld - Stock Titan
Is VolitionRx Limited a candidate for recovery playFed Meeting & Reliable Price Action Trade Plans - newser.com
Will a bounce in VolitionRx Limited offer an exit2025 Macro Impact & Real-Time Volume Analysis - newser.com
Is VolitionRX Limited stock resilient in recession scenariosJuly 2025 Setups & Weekly High Return Forecasts - newser.com
Will VolitionRX Limited stock boost dividends furtherNew Guidance & Accurate Buy Signal Notifications - newser.com
Beyond the Genome: Volition Showcases Revolutionary Nu.Q Platform for Epigenetic Drug Discovery - Stock Titan
VolitionRX (NYSEAMERICAN:VNRX) Trading 9% HigherShould You Buy? - MarketBeat
H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 By Investing.com - Investing.com Australia
VolitionRX (VNRX) Receives Reiterated Buy Rating by HC Wainwrigh - GuruFocus
VolitionRx (VNRX) Form 4: RSU Tax Withholding Reduces COO’s Shares - Stock Titan
Why analysts remain bullish on VolitionRx Limited stockQuarterly Trade Report & Safe Entry Zone Tips - newser.com
VolitionRx Partners with Hologic to Expand Access to Epigenetic Testing Services for Drug Developers - citybuzz
VNRX Stock: Analyst Maintains 'Buy' Rating with $5.00 Price Targ - GuruFocus
What indicators show strength in VolitionRx Limited2025 Volume Leaders & Verified Entry Point Signals - newser.com
$200M Market Opportunity: Volition Teams with $4B Healthcare Giant Hologic for Epigenetic Testing Service - Stock Titan
What drives VolitionRx Limited stock priceEx-Dividend Date Alerts & Free Popular Stock Picks Selection - earlytimes.in
VolitionRX Ltd (VNRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
1.44%
자본화:
|
볼륨(24시간):